Third Rock, J&J neuroscience spinout Rapport outlines IPO plans
The new year burst of biotech IPOs may have sputtered out months ago, but Rapport is a reminder that companies are still willing to test the waters
Source: fiercebiotech.com
Stay updated with breaking news from Abe Ceesay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new year burst of biotech IPOs may have sputtered out months ago, but Rapport is a reminder that companies are still willing to test the waters
The next miracle drug for lung cancer or epilepsy is just as likely to emerge from Arsenal Yards in Watertown or the shadow of Fenway Park.